• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症易感性综合征与甲状腺癌:双向短径的关键因素

Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street.

作者信息

Balinisteanu Ioana, Panzaru Monica-Cristina, Caba Lavinia, Ungureanu Maria-Christina, Florea Andreea, Grigore Ana Maria, Gorduza Eusebiu Vlad

机构信息

Endocrinology Department, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Endocrinology Department, "Sf. Spiridon" Hospital, 700106 Iasi, Romania.

出版信息

Biomedicines. 2023 Jul 29;11(8):2143. doi: 10.3390/biomedicines11082143.

DOI:10.3390/biomedicines11082143
PMID:37626640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10452453/
Abstract

Cancer predisposition syndromes are entities determined especially by germinal pathogenic variants, with most of them autosomal dominantly inherited. The risk of a form of cancer is variable throughout life and affects various organs, including the thyroid. Knowing the heterogeneous clinical picture and the existing genotype-phenotype correlations in some forms of thyroid cancer associated with these syndromes is important for adequate and early management of patients and families. This review synthesizes the current knowledge on genes and proteins involved in cancer predisposition syndromes with thyroid cancer and the phenomena of heterogeneity (locus, allelic, mutational, and clinical).

摘要

癌症易感性综合征是一类尤其由生殖细胞致病性变异所决定的疾病实体,其中大多数呈常染色体显性遗传。患某种癌症的风险在一生中是可变的,且会影响包括甲状腺在内的各种器官。了解与这些综合征相关的某些甲状腺癌形式的异质性临床表现以及现有的基因型 - 表型相关性,对于患者及其家庭的充分和早期管理至关重要。本综述综合了目前关于与甲状腺癌相关的癌症易感性综合征中涉及的基因和蛋白质以及异质性现象(基因座、等位基因、突变和临床)的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc67/10452453/53d4db81e675/biomedicines-11-02143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc67/10452453/53d4db81e675/biomedicines-11-02143-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc67/10452453/53d4db81e675/biomedicines-11-02143-g001.jpg

相似文献

1
Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street.癌症易感性综合征与甲状腺癌:双向短径的关键因素
Biomedicines. 2023 Jul 29;11(8):2143. doi: 10.3390/biomedicines11082143.
2
Diagnosis and Management of Hereditary Thyroid Cancer.遗传性甲状腺癌的诊断与管理
Recent Results Cancer Res. 2016;205:29-44. doi: 10.1007/978-3-319-29998-3_3.
3
Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition.甲状腺癌患者及疑似易患人群的癌症风险基因胚系致病性变异。
Cancer Med. 2022 Apr;11(8):1745-1752. doi: 10.1002/cam4.4549. Epub 2022 Feb 17.
4
[Hereditary thyroid carcinoma and its molecular diagnostics].[遗传性甲状腺癌及其分子诊断]
Cesk Patol. 2014 Apr;50(2):81-6.
5
Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.通过下一代测序检测到的儿童癌症患者中具有临床意义的种系变异的研究:文献综述。
J Med Genet. 2018 Dec;55(12):785-793. doi: 10.1136/jmedgenet-2018-105488. Epub 2018 Oct 4.
6
The LQT syndromes--current status of molecular mechanisms.长QT综合征——分子机制的现状
Z Kardiol. 1999 Apr;88(4):245-54. doi: 10.1007/s003920050283.
7
Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.甲状腺癌遗传学:2型多发性内分泌腺瘤病、非髓样家族性甲状腺癌以及与甲状腺癌相关的家族综合征。
Surg Oncol Clin N Am. 2009 Jan;18(1):39-52, viii. doi: 10.1016/j.soc.2008.08.002.
8
Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.遗传性甲状腺髓样癌的基因型-表型相关性
Recent Results Cancer Res. 2015;204:139-56. doi: 10.1007/978-3-319-22542-5_6.
9
Contribution of Inherited Variants to Hereditary Cancer Syndrome Predisposition.遗传变异对遗传性癌症综合征易感性的贡献。
Tohoku J Exp Med. 2022 Nov 22;258(4):319-325. doi: 10.1620/tjem.2022.J087. Epub 2022 Oct 27.
10
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.SEC23B基因的种系杂合变异与考登综合征相关,并在散发性甲状腺癌中富集。
Am J Hum Genet. 2015 Nov 5;97(5):661-76. doi: 10.1016/j.ajhg.2015.10.001. Epub 2015 Oct 29.

引用本文的文献

1
Paediatric Thyroid Carcinoma: The Genetic Revolution and Its Implications for Therapy and Outcomes.小儿甲状腺癌:基因革命及其对治疗和预后的影响
Cancers (Basel). 2025 May 2;17(9):1549. doi: 10.3390/cancers17091549.
2
Atypical thyroid manifestation in Cowden disease: a case report and literature review.考登病的非典型甲状腺表现:一例报告及文献复习
Front Pediatr. 2025 Mar 3;13:1499664. doi: 10.3389/fped.2025.1499664. eCollection 2025.
3
Recent Advances in Diagnostics and Therapeutics for Paediatric Thyroid Cancer.小儿甲状腺癌诊断与治疗的最新进展

本文引用的文献

1
Genotype-Phenotype Correlations in Autosomal Dominant and Recessive APC Mutation-Negative Colorectal Adenomatous Polyposis.常染色体显性和隐性 APC 突变阴性结直肠腺瘤性息肉病的基因型-表型相关性。
Dig Dis Sci. 2023 Jul;68(7):2799-2810. doi: 10.1007/s10620-023-07890-9. Epub 2023 Mar 2.
2
Cancer risk in patients with Peutz-Jeghers syndrome in Korea: a retrospective multi-center study.韩国皮杰特-杰格斯综合征患者的癌症风险:一项回顾性多中心研究。
Korean J Intern Med. 2023 Mar;38(2):176-185. doi: 10.3904/kjim.2022.208. Epub 2022 Dec 15.
3
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading.
J Paediatr Child Health. 2025 May;61(5):666-675. doi: 10.1111/jpc.70013. Epub 2025 Feb 11.
4
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma.小儿分化型甲状腺癌的分子图谱与治疗策略
Endocr Rev. 2025 May 9;46(3):397-417. doi: 10.1210/endrev/bnaf003.
5
Progressive Cachexia: Tuberculosis, Cancer, or Thyrotoxicosis? Disease-Directed Therapy and Atypical Courses of Autoimmune and Malignant Thyroid Diseases in a High Specialization Era: Case-Control Study with a Critical Literature Review.进行性恶病质:结核病、癌症还是甲状腺毒症?在高度专业化时代针对疾病的治疗以及自身免疫性和恶性甲状腺疾病的非典型病程:一项病例对照研究及批判性文献综述
Biomedicines. 2024 Nov 28;12(12):2722. doi: 10.3390/biomedicines12122722.
6
Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder.揭开肢端肥大症的遗传奥秘:探索遗传学在一种罕见疾病中的作用。
Curr Issues Mol Biol. 2024 Aug 20;46(8):9093-9121. doi: 10.3390/cimb46080538.
7
Integrated Diagnostics of Thyroid Nodules.甲状腺结节的综合诊断
Cancers (Basel). 2024 Jan 11;16(2):311. doi: 10.3390/cancers16020311.
《2022年世界卫生组织甲状腺肿瘤分类:命名和分级的新概念》
Endocr Relat Cancer. 2022 Dec 22;30(2). doi: 10.1530/ERC-22-0293. Print 2023 Feb 1.
4
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
5
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort.大型PTEN错构瘤肿瘤综合征(PHTS)患者队列中的基因型-表型关联
Eur J Med Genet. 2022 Dec;65(12):104632. doi: 10.1016/j.ejmg.2022.104632. Epub 2022 Oct 18.
6
Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG/AMP variant classification guidelines and impact on the MEN2 RET database.2型多发性内分泌肿瘤(MEN2)以及美国医学遗传学与基因组学学会(ACMG)/美国分子病理学会(AMP)变异分类指南的RET特异性修改及其对MEN2 RET数据库的影响
Hum Mutat. 2022 Dec;43(12):1780-1794. doi: 10.1002/humu.24486. Epub 2022 Oct 31.
7
Histopathological Features of Pendred Syndrome Thyroids Align with Differences in the Expression of Thyroid-Specific Markers, Apical Iodide Transporters, and Ciliogenesis Process.Pendred 综合征甲状腺的组织病理学特征与甲状腺特异性标志物、顶端碘转运体和纤毛发生过程表达的差异一致。
Endocr Pathol. 2022 Dec;33(4):484-493. doi: 10.1007/s12022-022-09732-2. Epub 2022 Oct 15.
8
Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach.2022 年世界卫生组织甲状腺肿瘤分类更新:一种标准化诊断方法。
Endocrinol Metab (Seoul). 2022 Oct;37(5):703-718. doi: 10.3803/EnM.2022.1553. Epub 2022 Oct 4.
9
Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.家族性腺瘤性息肉病和 MUTYH 相关息肉病的管理:新的认识。
Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101793. doi: 10.1016/j.bpg.2022.101793. Epub 2022 Mar 16.
10
Li-Fraumeni Syndrome: Mutation of Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.李-弗劳梅尼综合征: 是肿瘤遗传性易感性的生物标志物突变:治疗的新见解与进展
Cancers (Basel). 2022 Jul 27;14(15):3664. doi: 10.3390/cancers14153664.